bioRxivBioengineeringPreprint
Hydrodynamic shear enables enrichment of functional tumor antigen-reactive T cells
Prem Santhosh Subramanian, Michelle Fu, Layla C Semaan, Asfa Sultana Sher, Bhupinder S. ShergilliD, Steven C. GeorgeiD, Venktesh S. ShirureiD
Abstract
Adoptive T-cell therapies rely on the identification and expansion of rare tumor-reactive T cells, yet current enrichment strategies are limited by the low abundance of these cells and complexity of their functional enrichment. Here, we present a microfluidic platform that exploits hydrodynamic shear as a controllable parameter for enriching antigen-specific T cells through peptide-major histocompatibility complex (pMHC)-mediated capture. An eight-channel microfluidic device was engineered to simultaneously interrogate a range of wall shear stresses while maintaining uniform cell delivery, enabling systematic identification of shear conditions that maximize antigen-specific enrichment. Using engineered MART-1-specific Jurkat cells, we demonstrate that T-cell capture is jointly regulated by wall shear stress and pMHC density, with intermediate shear preferentially enriching antigen-specific cells over nonspecific binders. Translation of the optimal operating condition to a high-throughput single-shear device enabled approximately 35-fold enrichment of antigen-specific T cells from peripheral blood mononuclear cells containing only 0.05% target cells. We further show that peptide-MHC complexes isolated directly from melanoma whole-cell lysates support shear-dependent enrichment comparable to recombinant pMHCs. Finally, primary MART-1-specific CD8 T cells enriched using tumor-derived pMHCs retained the ability to recognize melanoma cells and upregulated the activation marker CD137 following antigen-specific stimulation. Together, these findings establish hydrodynamic shear as an orthogonal parameter for antigen-specific T-cell enrichment and provide a framework for integrating force-based selection with tumor-derived pMHCs to isolate functional antigen-specific T cells using tumor-derived pMHCs.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Programmable antigen-presenting scaffolds expand rare tumor-antigen-specific T cells from peripheral blood
Jessica Nicole DeVilla, Yoav Binenbaum, … Catherine J. Wu·bioRxiv·Oct 8, 2026
- Microfluidic T-Chip enables one-step clinical-scale T-cell purification from blood products for CAR T-cell manufacturing
Maheen Rana, Sophia E. Nigrovic, … Avanish Mishra·bioRxiv·Jul 31, 2026
- Tumors Exploit Dedicated Intracellular Vesicles to Program T cell Responses
E. W. Roberts, M. K. Ruhland, … M. F. Krummel·bioRxiv·Jul 4, 2019
- Softer substrates mechanical primes sustained and metabolically fit CD8+ T cells for anti-tumor activity
Aseel Alatoom, Jiranuwat Sapudom, … Jeremy C. M. Teo·bioRxiv·Apr 24, 2026
- Engineered CD47 protects T cells for enhanced antitumor immunity
S. A. Yamada-Hunter, J. Theruvath, … C. L. Mackall·bioRxiv·Jun 20, 2023
- Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
Brandon J. Sytsma, Vincent Allain, … Ryan S. Pawell·Scientific ReportsPeer-reviewed·Feb 17, 2025